PROVECTUS BIOPHARMACEUTICALS, INC. Cost of Revenue
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Cost of Revenue of $15.22 thousand for the 149-month period ending 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2014-08-07
- PROVECTUS BIOPHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2011 was $0.00.
| Period end | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 113 month | Cost of Goods and Services Sold 116 month | Cost of Goods and Services Sold 119 month | Cost of Goods and Services Sold 122 month | Cost of Goods and Services Sold 125 month | Cost of Goods and Services Sold 128 month | Cost of Goods and Services Sold 131 month | Cost of Goods and Services Sold 134 month | Cost of Goods and Services Sold 137 month | Cost of Goods and Services Sold 140 month | Cost of Goods and Services Sold 143 month | Cost of Goods and Services Sold 146 month | Cost of Goods and Services Sold 149 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | $15.22K 10-Q · filed 2014-08-07 | |||||||||||||
| 2014-03-31 | $15.22K 10-Q · filed 2014-05-08 | |||||||||||||
| 2013-12-31 | $15.22K 10-K · filed 2014-03-13 | |||||||||||||
| 2013-09-30 | $15.22K 10-Q · filed 2013-11-12 | |||||||||||||
| 2013-06-30 | $15.22K 10-Q · filed 2013-08-08 | |||||||||||||
| 2013-03-31 | $15.22K 10-Q · filed 2013-05-10 | |||||||||||||
| 2012-12-31 | $15.22K 10-K · filed 2013-03-14 | |||||||||||||
| 2012-09-30 | $15.22K 10-Q · filed 2012-11-08 | |||||||||||||
| 2012-06-30 | $15.22K 10-Q · filed 2012-08-08 | |||||||||||||
| 2012-03-31 | $15.22K 10-Q · filed 2012-05-09 | |||||||||||||
| 2011-12-31 | $0.00 10-K · filed 2012-03-14 | $15.22K 10-K · filed 2012-03-14 | ||||||||||||
| 2011-09-30 | $15.22K 10-Q · filed 2011-11-08 | |||||||||||||
| 2011-06-30 | $15.22K 10-Q · filed 2011-08-09 |